Fu'an Pharmaceutical: Metronidazole Sodium Chloride Injection Obtains Drug Registration Certificate

Fuan Pharmaceuticals announced on April 13 that its wholly-owned subsidiary, Fuan Pharmaceuticals Group Ningbo Tianheng Pharmaceutical Co., Ltd., recently received the drug registration certificate for Metronidazole and Sodium Chloride Injection issued by the National Medical Products Administration. This drug is suitable for adult gynecological pelvic inflammatory disease caused by sensitive bacteria, as well as for the combined surgical treatment of suppurative appendicitis and gangrenous appendicitis.